Blog
Gonadorelin research: why pulsatile delivery and diagnosis matter
Timing and clinical context can matter as much as a hormone’s name. The cohort describes a defined medical process, not a general fertility benefit.
Evidence discussed: Retrospective human cohort; clinical GnRH context.
What the researchers studied
A single-center retrospective cohort examined pulsatile GnRH therapy in 66 women with functional hypothalamic amenorrhea. Researchers reported ovulation, pregnancy and birth outcomes across cycles using a clinical pump system. [1]
How to interpret the result
This was not a randomized comparison of a shop product. Diagnosis, specialist assessment and pulsatile delivery are essential to interpreting the findings. They cannot be transferred to unsupervised exposure or other causes of infertility.
What readers can take from it
Timing and clinical context can matter as much as a hormone’s name. The cohort describes a defined medical process, not a general fertility benefit.
This original editorial summary provides no diagnosis, dosing or treatment advice. The study did not test or certify a PeptiKing product.
Source
[1] Quaas et al., 25-year pulsatile GnRH cohort (2022). PMID: 36378460. Based on the PubMed-indexed abstract and record; full-text methods were not independently reviewed.